Search hospitals > Minnesota > Minneapolis

Mercy Hospital

Claim this profile
Minneapolis, Minnesota 55433
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
Conducts research for Relapse
393 reported clinical trials
15 medical researchers
Photo of Mercy Hospital in MinneapolisPhoto of Mercy Hospital in MinneapolisPhoto of Mercy Hospital in Minneapolis

Summary

Mercy Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Relapse and other specialties. Mercy Hospital is involved with conducting 393 clinical trials across 555 conditions. There are 15 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.

Area of expertise

1Skin Cancer
Global Leader
Mercy Hospital has run 180 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Mercy Hospital has run 107 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
ER positive
HER2 negative

Top PIs

Clinical Trials running at Mercy Hospital

Breast Cancer
Esophageal Adenocarcinoma
Lung Cancer
Skin Cancer
Esophageal Carcinoma
Prostate Cancer
Esophageal cancer
Gastroesophageal Junction Adenocarcinoma
Breast cancer
Stomach Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mercy Hospital?
Where is Mercy Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Mercy Hospital accept?
What awards or recognition has Mercy Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security